PALADIN®

Carotid Post-Dilation Balloon with Integrated Embolic Protection

Despite the widespread use of EPDs, the risk of stroke remains one of the biggest challenges regarding carotid artery stenting especially in the critical procedure stage of post-dilation. The PALADIN Carotid Post-Dilation Balloon with Integrated Embolic Protection contains an angioplasty balloon and an integrated 40 μm filter, coupled together for the first time. Whether the operator chooses to use a distal filter or a proximal occlusion as a primary method of embolic protection, the additional protection provided by the PALADIN device will result in more efficient carotid stent procedures.

Easy Single-Step Deployment & Removal

Stroke Protection
When it Matters Most

Ischemic stroke risk remains unacceptably high in carotid stent procedures, even with the use of conventional embolic protection devices. Some groups such as symptomatic patients and octogenarians are at higher risk than others.¹

“The highest risk of embolization during CAS is in post-dilation. Therefore, the biggest opportunity to reduce risk is during this phase.”
Dr. William Gray

Size Matters
Paladin® Captures What Others Miss2,3

  • The Paladin® EPS captures smaller emboli. Paladin® EPS pore sizes ≈ 40 μm while commercially available filters are all ≥ 100 μm.
  • Better wall apposition (capture efficiency) by being able to adjust the filter diameter to suit the patient’s anatomy.

More Information

Download Instructions for Use (IFU):

References

  1. Carotid Artery Stenting in Octogenarians. Periprocedural Stroke Risk Predictor Analysis From the Multicenter Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events (CAPTURE 2) Clinical Trial Stroke. 2010; 41: 757-764 doi: 10.1161/STROKEAHA.109.569426; Stroke. 2007; 38: 707-714 doi: 10.1161/01.STR.0000250047.01624.fd
  2. Contego Medical – Clinical Evaluation Report, December 2014
  3. Siewiorek GM, Wholey MH, Finol EA. A comparative analysis of bench-top performance assessment of distal protection filters in transient flow conditions. Journal of Endovascular Therapy 2012;19(2):249-260.
  4. Bench top testing data on file at Contego Medical